warning

Alert: Because flu cases are on the rise, children 12 and younger will be restricted from visiting hospitals and certain inpatient facilities. Learn more.

Research and Clinical Trials

Title  
LEMTRADA Infusion Vital Signs Study - OBS14379
Brief Description  
The research study will be conducted in adult subjects with relapsing forms of multiple sclerosis for which the decision to prescribe LEMTRADA has been made. The purpose of study is to further characterize the safety profile of LEMTRADA by systematic observation of vital signs during and shortly after LEMTRADA infusions of the first treatment course. Patient participation will last for approximately 2 to 7 week.
Who may be Eligible  
Adults patients diagnosed with relapsing multiple sclerosis who are planning treatment with LEMTRADA.
Start Date  
04/01/2016
IRB Number  
05-16-24B
Principal Investigator  
Graves, Donna
Contact Name  
Joyce

For More Information, Contact  Joyce  , Pitner
Phone:  (704) 446-1349  Fax:  (704) 446-1915  
Email:  Joyce.Pitner@carolinashealthcare.org
Address:Neurosciences Institute, Neurology-Charlotte 1010 Edgehill Road North Charlotte, NC 28207
Close